FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer

被引：0
|
作者：
Cuilan Sun
Weiwei Gao
Jiatao Liu
Hao Cheng
Jiqing Hao
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Oncology
[2] the First Affiliated Hospital of Anhui Medical University,Department of Pharmacy
来源：
Respiratory Research | / 21卷
关键词：
Fibrinogen-like-protein 1; Epidermal growth factor receptor; Non-small cell lung cancer; Gefitinib resistance; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
    Sun, Cuilan
    Gao, Weiwei
    Liu, Jiatao
    Cheng, Hao
    Hao, Jiqing
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [2] CLINICAL CHARACTERISTICS OF ACQUIRED RESISTANCE TO GEFITINIB IN NON-SMALL CELL LUNG CANCER
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Shin, Kyeong-Cheol
    Lee, Jae Chol
    Ryu, Jeong Seon
    Jang, Seung Hoon
    Kim, Sun Young
    Jang, Tae Won
    RESPIROLOGY, 2010, 15 : 37 - 37
  • [3] Clinical Characteristics of Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
    Lee, Kye Young
    Kim, Hee Joung
    Kim, Young-Chul
    Kim, Kyu-Sik
    Oh, In-Jae
    Ban, Hee Jung
    Lee, Sung Yong
    Jang, Tae Won
    Shin, Kyeong-Cheol
    Lee, Gwan Ho
    Lce, Jae Chol
    Ryu, Jeong-Seon
    Jang, Seung Hoon
    Lee, Jeong Eun
    Kim, Sun Young
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S396 - S397
  • [4] RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis
    Shuo Wu
    Chenxi Hu
    Pengwu Hu
    Wei He
    Kaiyuan Hui
    Xiaodong Jiang
    Journal of Cancer Research and Clinical Oncology, 151 (4)
  • [5] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [6] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [7] miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
    Ge, Peng
    Cao, Lei
    Chen, Xin
    Jing, Ruijun
    Yue, Wanxia
    BMC CANCER, 2019, 19 (01)
  • [8] Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines
    Wen, Chunjie
    Xu, Ge
    He, Shuai
    Huang, Yutang
    Shi, Jingjing
    Wu, Lanxiang
    Zhou, Honghao
    JOURNAL OF CANCER, 2020, 11 (13): : 3816 - 3826
  • [9] miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
    Peng Ge
    Lei Cao
    Xin Chen
    Ruijun Jing
    Wanxia Yue
    BMC Cancer, 19
  • [10] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
12345